日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Postmarket Drug Safety-Related Actions Before and After the US Food and Drug Administration Amendments Act

美国食品药品监督管理局修正案颁布前后的上市后药品安全相关行动

期刊:Jama Internal Medicine
影响因子:23.3
doi:10.1001/jamainternmed.2025.6566
Doernberg, Harry; Wallach, Joshua D; Jeffery, Molly M; Mooghali, Maryam; Ramachandran, Reshma; Ross, Joseph S
发表日期：2026
文献求助 收藏

Postmarket Safety Actions for Novel Oncology Drugs Granted FDA's Accelerated Approval

获得FDA加速批准的新型肿瘤药物上市后安全性评估

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2025.53764
Mooghali, Maryam; Wallach, Joshua D; Mitchell, Aaron P; Ross, Joseph S; Ramachandran, Reshma
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Key Information Influencing Patient Decision-Making About AI in Health Care: Survey Experiment Study

影响患者对医疗保健领域人工智能决策的关键信息：调查实验研究

期刊:Journal of Medical Internet Research
影响因子:
doi:10.2196/75615
Zhu, Xuan; Stroud, Austin M; Minteer, Sarah A; Yoo, Dong Whi; Ridgeway, Jennifer L; Mooghali, Maryam; Miller, Jennifer E; Barry, Barbara A
发表日期：2026
文献求助 收藏

Research Derived From Medicare's Coverage With Evidence Development Program

源自医疗保险循证发展计划的研究

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2025.5077
Janda, Guneet S; Moneer, Osman; Mooghali, Maryam; Ramachandran, Reshma; Wallach, Joshua D; Dhruva, Sanket S; Ross, Joseph S
发表日期：2025
文献求助 收藏

Nonconcurrent Control Use in FDA Approval of High-Risk Medical Devices

非同步对照在FDA批准高风险医疗器械中的应用

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2025.6230
Mooghali, Maryam; Dhruva, Sanket S; Hakimian, Hollin R L; Rathi, Vinay K; Kadakia, Kushal T; Ross, Joseph S
发表日期：2025
文献求助 收藏

Associations Between Surrogate Markers and Clinical Outcomes for Nononcologic Chronic Disease Treatments

非肿瘤慢性疾病治疗中替代标志物与临床结果之间的关联

期刊:Journal of the American Medical Association
影响因子:55
doi:10.1001/jama.2024.4175
Wallach, Joshua D; Yoon, Samuel; Doernberg, Harry; Glick, Laura R; Ciani, Oriana; Taylor, Rod S; Mooghali, Maryam; Ramachandran, Reshma; Ross, Joseph S
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Premarket Evidence and Postmarketing Requirements for Real-Time Oncology Review Indication Approvals

实时肿瘤学审查适应症批准的上市前证据和上市后要求

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2024.9233
Mooghali, Maryam; Mohammad, Ayman; Wallach, Joshua D; Mitchell, Aaron P; Ross, Joseph S; Ramachandran, Reshma
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Premarket Pivotal Trial End Points and Postmarketing Requirements for FDA Breakthrough Therapies

FDA突破性疗法上市前关键试验终点和上市后要求

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2024.30486
Mooghali, Maryam; Wallach, Joshua D; Ross, Joseph S; Ramachandran, Reshma
发表日期：2024
文献求助 收藏

Trustworthy and ethical AI-enabled cardiovascular care: a rapid review

值得信赖且符合伦理的人工智能赋能心血管护理：快速综述

期刊:BMC Medical Informatics and Decision Making
影响因子:3.8
doi:10.1186/s12911-024-02653-6
Mooghali, Maryam; Stroud, Austin M; Yoo, Dong Whi; Barry, Barbara A; Grimshaw, Alyssa A; Ross, Joseph S; Zhu, Xuan; Miller, Jennifer E
发表日期：2024
文献求助 收藏

Direct oral anticoagulant approvals by four major regulatory agencies: a cross-sectional analysis of premarket and postmarket evidence

四大监管机构对直接口服抗凝剂的批准：上市前和上市后证据的横断面分析

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2024-090376
Mooghali, Maryam; Zhou, Tianna; Ross, Joseph S
发表日期：2024
文献求助 收藏